ATE189263T1 - Auswahl von effizient ziel-rns spaltenden ribozymen - Google Patents
Auswahl von effizient ziel-rns spaltenden ribozymenInfo
- Publication number
- ATE189263T1 ATE189263T1 AT91916167T AT91916167T ATE189263T1 AT E189263 T1 ATE189263 T1 AT E189263T1 AT 91916167 T AT91916167 T AT 91916167T AT 91916167 T AT91916167 T AT 91916167T AT E189263 T1 ATE189263 T1 AT E189263T1
- Authority
- AT
- Austria
- Prior art keywords
- rna
- ribozymes
- cliping
- selection
- efficient target
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1041—Ribosome/Polysome display, e.g. SPERT, ARM
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55372990A | 1990-07-16 | 1990-07-16 | |
PCT/US1991/005017 WO1992001806A1 (en) | 1990-07-16 | 1991-07-16 | Selection of ribozymes that efficiently cleave target rna |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE189263T1 true ATE189263T1 (de) | 2000-02-15 |
Family
ID=24210504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT91916167T ATE189263T1 (de) | 1990-07-16 | 1991-07-16 | Auswahl von effizient ziel-rns spaltenden ribozymen |
Country Status (7)
Country | Link |
---|---|
US (1) | US5616459A (de) |
EP (1) | EP0600877B1 (de) |
AT (1) | ATE189263T1 (de) |
AU (1) | AU651380B2 (de) |
CA (1) | CA2087519C (de) |
DE (1) | DE69131942T2 (de) |
WO (1) | WO1992001806A1 (de) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5496698A (en) * | 1992-08-26 | 1996-03-05 | Ribozyme Pharmaceuticals, Inc. | Method of isolating ribozyme targets |
US5693535A (en) * | 1992-05-14 | 1997-12-02 | Ribozyme Pharmaceuticals, Inc. | HIV targeted ribozymes |
US6017756A (en) * | 1992-05-14 | 2000-01-25 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting hepatitis B virus replication |
WO1994013793A1 (en) * | 1992-12-04 | 1994-06-23 | Apollon, Inc. | Compounds and methods for the treatment of leukemias |
FR2723371B1 (fr) * | 1994-08-02 | 1996-10-31 | Inst Nat Sante Rech Med | Oligonucleotide reconnaissant une sequence d'acide nucleique a structure non lineaire, application a des fins therapeutiques et procede de preparation |
JPH10503654A (ja) * | 1994-08-05 | 1998-04-07 | ワーナー−ランバート・コンパニー | レトロウイルスの感染の治療におけるトランスドミナント・ネガティブ・レトロウイルス・インテグラーゼの使用方法 |
US6274369B1 (en) * | 1996-02-02 | 2001-08-14 | Invitrogen Corporation | Method capable of increasing competency of bacterial cell transformation |
US6139817A (en) * | 1996-10-15 | 2000-10-31 | Smithkline Beecham Corporation | Method for determining gene essentiality in a pathogen |
JPH10191990A (ja) * | 1996-10-15 | 1998-07-28 | Smithkline Beecham Corp | 病原体に必須の遺伝子の測定法 |
AU5927598A (en) | 1997-01-23 | 1998-08-18 | Immusol Incorporated | Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
JP2001525667A (ja) * | 1997-05-09 | 2001-12-11 | リボザイム・ファーマシューティカルズ・インコーポレーテッド | C−rafの発現レベルに関係した疾患または状態の酵素核酸処置 |
US6548657B1 (en) | 1997-06-09 | 2003-04-15 | Ribozyme Pharmaceuticals, Inc. | Method for screening nucleic acid catalysts |
US6280936B1 (en) | 1997-06-09 | 2001-08-28 | Ribozyme Pharmaceuticals, Inc. | Method for screening nucleic acid catalysts |
US6183959B1 (en) | 1997-07-03 | 2001-02-06 | Ribozyme Pharmaceuticals, Inc. | Method for target site selection and discovery |
EP1007099A4 (de) * | 1997-07-11 | 2004-11-24 | Univ Brandeis | Methode zur induktion von apoptose mittels senkung des thiamin-spiegels |
JP2001514873A (ja) * | 1997-08-20 | 2001-09-18 | ソーマジェニックス インコーポレイテッド | 結合特性が改善されたアンチセンスおよびアンチジーン治療薬並びにそれらの使用方法 |
US6316612B1 (en) | 1997-08-22 | 2001-11-13 | Ribozyme Pharmaceuticals, Inc. | Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides |
US6387703B1 (en) * | 1997-10-07 | 2002-05-14 | Smithkline Beecham Corporation | Method for modulating gene expression |
US6127535A (en) * | 1997-11-05 | 2000-10-03 | Ribozyme Pharmaceuticals, Inc. | Nucleoside triphosphates and their incorporation into oligonucleotides |
US6617438B1 (en) | 1997-11-05 | 2003-09-09 | Sirna Therapeutics, Inc. | Oligoribonucleotides with enzymatic activity |
US6440695B1 (en) * | 1998-04-17 | 2002-08-27 | Whitehead Institute For Biomedical Research | Method for producing diverse libraries of encoded polypeptides |
DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
GB9912965D0 (en) * | 1999-06-03 | 1999-08-04 | Oxford Biomedica Ltd | In vivo selection method |
US7829693B2 (en) * | 1999-11-24 | 2010-11-09 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
US6541168B2 (en) * | 2000-04-28 | 2003-04-01 | Corning Incorporated | Vacuum ultraviolet transmitting direct deposit vitrified silicon oxyfluoride lithography glass photomask blanks |
US6808876B1 (en) * | 2000-05-02 | 2004-10-26 | Immusol, Inc. | Cellular regulators of infectious agents and methods of use |
US8546143B2 (en) | 2001-01-09 | 2013-10-01 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inhibiting expression of a target gene |
US20040002083A1 (en) * | 2002-01-29 | 2004-01-01 | Ye Ding | Statistical algorithms for folding and target accessibility prediction and design of nucleic acids |
WO2004050674A2 (en) * | 2002-12-04 | 2004-06-17 | Algos Therapeutics, Inc. | Methods and materials for modulating trpm2 |
EP1570043B1 (de) * | 2002-12-12 | 2013-07-24 | Novartis Vaccines and Diagnostics, Inc. | In-line-bluttestvorrichtung und-verfahren mit biochips |
US20050026290A1 (en) * | 2003-08-01 | 2005-02-03 | Ciardi Joseph Anthony | Inhibiting gene expression with dsRNA |
US20050176125A1 (en) * | 2003-12-23 | 2005-08-11 | Rosetta Inpharmatics Llc | Alternatively spliced isoform of CDC25A phosphatase and methods of use |
US20050266469A1 (en) * | 2004-05-25 | 2005-12-01 | Raymond Christopher K | Alternatively spliced isoforms of checkpoint kinase 1 (CHK1) |
US7150969B2 (en) * | 2004-06-04 | 2006-12-19 | Rosetta Inpharmatics Llc | Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2) |
US8999672B2 (en) * | 2005-01-28 | 2015-04-07 | James A. Williams | Compositions and processes for improved plasmid DNA production |
US10513711B2 (en) | 2014-08-13 | 2019-12-24 | Dupont Us Holding, Llc | Genetic targeting in non-conventional yeast using an RNA-guided endonuclease |
EP3215611B1 (de) | 2014-11-06 | 2019-08-21 | E. I. du Pont de Nemours and Company | Peptidvermittelte freisetzung von rna-geführter endonuklease in zellen |
EP3362560B1 (de) | 2015-10-12 | 2022-08-10 | DuPont US Holding, LLC | Geschützte dna-schablonen zur genmodifizierung und erhöhten homologen rekombination in zellen und verfahren zur verwendung |
WO2024026474A1 (en) | 2022-07-29 | 2024-02-01 | Regeneron Pharmaceuticals, Inc. | Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680265A (en) * | 1984-09-25 | 1987-07-14 | Eli Lilly And Company | Method of selecting recombinant DNA-containing streptomyces |
US5037746A (en) * | 1986-12-03 | 1991-08-06 | University Patents, Inc. | RNA ribozyme polymerases, and methods |
US5144019A (en) * | 1989-06-21 | 1992-09-01 | City Of Hope | Ribozyme cleavage of HIV-I RNA |
-
1991
- 1991-07-16 AU AU85175/91A patent/AU651380B2/en not_active Expired
- 1991-07-16 DE DE69131942T patent/DE69131942T2/de not_active Expired - Lifetime
- 1991-07-16 WO PCT/US1991/005017 patent/WO1992001806A1/en active IP Right Grant
- 1991-07-16 CA CA002087519A patent/CA2087519C/en not_active Expired - Lifetime
- 1991-07-16 AT AT91916167T patent/ATE189263T1/de not_active IP Right Cessation
- 1991-07-16 EP EP91916167A patent/EP0600877B1/de not_active Expired - Lifetime
-
1992
- 1992-08-18 US US07/931,560 patent/US5616459A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0600877A4 (en) | 1994-08-17 |
DE69131942T2 (de) | 2000-06-29 |
EP0600877B1 (de) | 2000-01-26 |
AU651380B2 (en) | 1994-07-21 |
EP0600877A1 (de) | 1994-06-15 |
AU8517591A (en) | 1992-02-18 |
CA2087519A1 (en) | 1992-01-17 |
DE69131942D1 (de) | 2000-03-02 |
CA2087519C (en) | 2002-10-22 |
US5616459A (en) | 1997-04-01 |
WO1992001806A1 (en) | 1992-02-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE189263T1 (de) | Auswahl von effizient ziel-rns spaltenden ribozymen | |
ATE187491T1 (de) | Isolierung, selektion und vermehrung von tierischen transgen-stammzellen | |
NO933337D0 (no) | Polyoksypropylen/polyoksyetylen-kopolymerer med forbedretbiologisk aktiviteter | |
DE69330945D1 (de) | Tierzellenkultur | |
DE69811867T2 (de) | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten | |
DE69024965T2 (de) | Dehydrodidemnin b | |
ID26620A (id) | Penghambatan kinase raf yang menggunakan urea-urea heterosiklik yang disubstitusi | |
ES2143620T3 (es) | Polipeptidos modificados con actividad biologica incrementada. | |
ATE186738T1 (de) | Kohlenhydratmodifizierte cytostatika | |
PT938308E (pt) | Agentes antiparasitarios | |
DE69702705D1 (de) | Kondensierte pyrrolo(2,3-c) carbazole-6-one die die aktivität von gamma interferon potenzieren | |
MX9605088A (es) | Metodos para proliferar y diferenciar celulas b y sus usos. | |
MX9606369A (es) | Supresion del crecimiento de celulas tumorales mediante el ectodominio de syndecan-1. | |
NL191634B (nl) | Grondbewerkingsstelsel, en beiteldraagblok daarvoor. | |
GB8406544D0 (en) | Pyrethroid compositions | |
FI944563A0 (fi) | Mikro-organismeja, valmistusmenetelmä ja käyttö | |
NL7903791A (nl) | Membraan uit elastisch materiaal, evenals opstelling en bediening daarvan in bijbehorende huizen. | |
DE69016693T2 (de) | Züchtung von transformierten Mikroorganismen. | |
NL188130C (nl) | Audioversterker en voedingstoestel met hoog rendement en gering gewicht. | |
DE69814148D1 (de) | Zielspezifische abgabe zum nukleus mittels protein h von streptococcus | |
EA199700369A1 (ru) | Трансгенные гвоздики, проявляющие пролонгированную жизнь после сбора цветков | |
ES2158441T3 (es) | Arilheterociclos con actividad herbicida. | |
ES2113765T3 (es) | Dimaleato de n,n-dietil-8,8-dipropil-2-azaespiro(4.5)decano-2-propanamina. | |
JPS52147050A (en) | Amplifier | |
SU1536770A1 (ru) | Хлорид бензилгексаметилентетраммония, обладающий бактерицидной активностью в отношении сульфатвосстанавливающих бактерий и культур pseudomonas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |